Our History
Mission Statement
Facilities Worldwide
Stiefel Laboratories News
Skin Care Matters To Us
Compliance Program
If you are a member of the press, please contact:
Erin Bacher
Associate Director, Global Public Relations
6340 Sugarloaf Parkway
Suite 400
Duluth, GA 30097
Voice: 770.945.0101
Fax: 770.945.5424
erin.bacher@stiefel.com
Amy E. Button
Associate Manager, Global Public Relations
6340 Sugarloaf Parkway
Suite 400
Duluth, GA 30097
Voice: 770.945.0101
Fax: 770.945.5424
amy.button@stiefel.com
Jul 22 2009
GlaxoSmithKline Completes Acquisition of Stiefel
Jun 2 2009
Stiefel Laboratories reaps first fruits of Barrier acquisition with completion of pivotal phase III clinical trial for 200 mg Hyphanox™ (itraconazole) tablet
Apr 20 2009
GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business
Mar 6 2009
Stiefel Laboratories Expands U.S. Consumer HealthCare Division: Launches Impruv® Dry Skin Product Line At Walgreens
Dec 4 2008
Stiefel Laboratories Announces The Expansison Of Its REVALÉSKIN® Skin Care Line With Three New Products
Oct 20 2008
Bob Cunard appointed President of Glades Pharmaceuticals
Aug 6 2008
Stiefel Laboratories Completes Acquisition of Barrier Therapeutics
Aug 5 2008
Stiefel Laboratories, Inc. Successfully Completes Tender Offer For Shares Of Barrier Therapeutics, Inc.
<Previous
1
2
3
4
5
...
Next>